Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial LoomsInvestors Business Daily • 08/11/22
Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in ChinaGlobeNewsWire • 08/04/22
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in ChinaPRNewsWire • 08/04/22
Sanofi appoints new Heads of U.S. General Medicines, and North America Vaccines and Consumer HealthcarePRNewsWire • 08/03/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYPRNewsWire • 08/01/22
Sanofi SA (SNY) CEO Paul Hudson on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/28/22
Sanofi partners with Howard University in an unprecedented pharmacy fellowship programPRNewsWire • 07/26/22
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitisGlobeNewsWire • 07/14/22
Press Release: Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxisGlobeNewsWire • 07/10/22
Press Release: Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxisGlobeNewsWire • 07/10/22
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/07/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/06/22